Presentation of motor neuron disease in a patient with weight loss and acute-on-chronic respiratory failure
- Tak Wai Chan
- Acute Medicine, University Hospitals Plymouth NHS Trust, Plymouth, UK
- Correspondence to Dr Tak Wai Chan; tak.chan@nhs.net
Abstract
A previously fit and well 72-year-old man was referred to the acute medical unit with acute shortness of breath and confusion. He had presented 6 months earlier to his General Practitioner with a 6-month history of weight loss and lethargy. Despite CT imaging and extensive blood tests, no cause was found. He was having ongoing outpatient investigations, including a respiratory review leading up to his admission; the deterioration in his condition also coincided with the implementation of the COVID-19 lockdown. On admission, he was found to be in acute-on-chronic type 2 respiratory failure; examination revealed scattered fasciculations. Further inpatient electromyography (EMG) and nerve conduction study (NCS) confirmed motor neuron disease (MND). This case highlighted the importance of considering neuromuscular causes for acute respiratory failure in acute presentations and demonstrated the challenges in the diagnosis of MND in those presenting atypically with non-specific symptoms and the limitations of remote consultations in complex cases.
Background
Motor neuron disease (MND) is a neurodegenerative disorder that has a prevalence in the UK of 4–4.7 in 100 000.1 The term MND encompasses different forms of the disease, which patients may present with upper motor neuron and/or lower motor neuron signs. Spinal onset and bulbar onset MND represent most cases and typically manifest with progressive, unilateral weakness and stiffness in arms and legs. In a smaller proportion of patients who develop MND with respiratory onset, patients may present atypically, and its symptoms may be more insidious thus posing diagnostic challenges.
In this case, we describe the presentation of acute-on-chronic type 2 respiratory failure in a 72-year-old man under investigation for progressive shortness of breath on exertion (SOBOE), weight loss and lethargy. The case discusses the opportunities for potential earlier identification of neuromuscular disease as a differential diagnosis.
Case presentation
A previously fit and well 72-year-old retired man, first presented to his GP with a 6-month history of weight loss, lack of appetite, increasing fatigue, and shoulder and neck myalgia. Despite multiple investigations in the following 6 months from his first presentation, no cause of his symptoms was found. He was later referred to the hospital by his GP with worsening shortness of breath and intermittent confusion in the week leading up to his admission.
On further history taking, he reported worsening symptoms over the past 6 months with SOBOE, poor sleep at night and daytime sleepiness. He reported unintentional weight loss >1 stone with lack of appetite. He denied dysphagia, haemoptysis, changes in bowel habits or fever. He has no significant medical history and does not require any regular medications. There is no family history of malignancies. He is an ex-smoker with a 25 pack-year smoking history.
At the time of examination on the medical assessment unit, he had been started on a venturi mask for compensated type 2 respiratory failure.
On examination, the patient appeared cachectic. He was comfortable at rest but remained tachypnoeic with respiratory rate of 28, oxygen saturation (spO2) of 96% on 24% via venturi mask. Other observations were within normal limits. Neurological examination demonstrated scattered fasciculations in his hands, chest wall and anterior thigh and brisk reflexes. He was noted to have a weak ‘husky’ voice. Medical Research Council's (MRC) scale of muscle power was 5/5 throughout with sensation intact; he denied diplopia, and there was no ptosis.
A differential diagnosis of neuromuscular disorder was considered at the time; other causes such as chronic obstructive pulmonary disease and sleep apnoea were less likely but not excluded.
Investigations
From patient’s first presentation to the GP up to admission, he has had multiple investigations for his presenting symptoms and has been reviewed by different specialties (figure 1).
Timeline of patient’s journey prior to admission. CXR, Chest radiograph; CT TAP, Computed Tomography of the Thorax, Abdoment and Pelvis; ENT, Ear, Nose and Throat; NAD, no abnormality detected; SOB, Shortness of breath; GP, General Practitioner; 2WW, 2 week wait; SOBOE, shortness of breath on exertion; V/Q scan, ventilation-perfusion scan.
He was initially investigated for malignancy due to his smoking history; in addition, he was also investigated for inflammatory/rheumatological disorders, haematological disorders and coeliac disease. His blood tests initially showed polycythaemia, and CT Thorax, Abdomen and Pelvis (CT TAP) showed an incidental right retrosternal multinodular goitre. Otherwise, all investigations were unremarkable.
While he was undergoing investigations for weight loss and generalised weakness, he developed SOBOE.
Haematology and the ENT team have reviewed the patient, noting his general decline with shortness of breath at rest, worsening exercise tolerance and a weak cough. Following further investigations including an ultrasound scan of the neck and abdomen, nasoendoscopy and further blood tests, it was felt that he did not have a primary bone marrow disorder, and his symptoms were not caused by the goitre.
At the time of his spirometry, it was noted that his oxygen saturations were 93%, and the patient struggled to exhale for 6 seconds when measuring his forced vital capacity (figures 2 and 3). The outcome was suggestive of a restrictive pattern.
Patient’s spirogram demonstrating restrictive pattern.
Table of patient’s spirometry value. FEV1, forced expiratory volume in one second; FVC, forced vital capacity.
He was subsequently reviewed by a chest physician in a telephone clinic 3 weeks prior to his hospital admission; respiratory muscle tests, along with a ventilation-perfusion scan (V/Q scan) and an arterial blood gas (ABG) were arranged for further investigation.
On admission, he was found to have compensated type 2 respiratory failure on arterial blood gas (figure 4). MRI head and spine were normal. EMG and NCS were suggestive of MND (figure 5), probably the form of Amyotrophic Lateral Sclerosis (ALS) with no clear evidence of bulbar involvement.
Patient’s arterial blood gas. HCO3-, bicarbonate; SaO2, oxygen saturations; FiO2, fraction of inspired oxygen.
Patient’s EMG demonstrating fasciculation in right biceps brachii.
The patient was started on non-invasive ventilation (NIV), a cough assist machine and a prophylactic percutaneous endoscopic gastrostomy (PEG) tube has been inserted to assist in nutritional intake. He has now been discharged and is being followed up by the home ventilation team and the MND team.
Discussion
The differential diagnoses for weight loss and fatigue are very broad; without accompanying motor signs, MND may not be considered at the first instance. There are limited case reports and studies on weight loss as a presenting complaint, as weight loss is more often used as an outcome measure of MND as a result of dysphagia, fatigue, muscular atrophy and hypermetabolic rate observed in these patients. Nonetheless, two reports found that up to 20% of patients have lost over 10% of premorbid weight at the time of diagnosis.2 Increasing weight loss at the time of diagnosis has also been found to be a negative prognostic indicator.3
Although not common, weight loss can occur as part of early respiratory involvement, along with other symptoms such as SOBOE, orthopnoea, unrefreshing sleep, weak cough and the use of accessory muscles.4 Literature suggests that only 1%–3% of patients with ALS present with respiratory symptoms.5 Respiratory failure is often a late complication of MND.6
Early diagnosis allows patients more time to come to terms with the diagnosis and plan for the future. Currently, there is no cure for MND; however, the National Institue for Health and Care Excellence (NICE)recommends riluzole in some patients with early ALS, which may prolong time from mechanical ventilation.1 This may enable patients to maintain independence, achieve better symptomatic relief and quality of life.
We recognise the difficulty in early diagnosis of MND in patients who present atypically; they often undergo extensive investigations.4 7 For our patient, he has been to his GP and other medical professionals on several occasions. In hindsight, there were some subtle signs of a progressive decline in respiratory function and weakness at different visits that may elude to MND as a differential diagnosis. We wish to highlight the atypical presentation of MND and encourage each physician to consider MND as an alternative diagnosis in patients with unexplained weight loss, shortness of breath and weakness.
General Practitioner’s perspective
‘When the patient first presented with significant weight loss, subtle weakening of his voice and generalised aches and pains, multiple investigations and referrals were carried out to investigate for malignancy and other possible causes. Although there were some abnormal results (as above), these were felt to be “red-herrings” and not an explanation for his symptoms. Unfortunately the deterioration in the patient’s condition occurred as we went into COVID lockdown, meaning all consultations both in primary and secondary care had to take place remotely. This led the to him not being seen by a GP or the respiratory consultation over a period of about 3 months, during which time he had also started to develop generalised weakness.
Although this was an atypical presentation there were some clues that, on reflection, pointed towards a neuromuscular degenerative cause, including the weakened voice and the restrictive picture on spirometry.
Due to the low incidence of MND, the average GP is unlikely to see more than one new case in their career. As a presenting symptom of weight loss is a red flag for cancer, it is easy to forget that there are other explanations that need to be explored once malignancy is ruled out.
Mr W is now home and managing really well. We are beginning to undertake advanced care planning to allow him to take control of his future’.
Learning points
-
To consider neurological causes and undertake a neurological examination in patients with unexplained weight loss.
-
Caution must be taken when carrying out repeat remote consulting with patients with unexplained symptoms.
Acknowledgments
Dr Bommayya has been involved in the care of the patient, and I would like to thank him for his advice on the writing of this report. I would also like to thank Dr Cooper, who has been the attending GP throughout the patient’s presentation. It has been immensely helpful to be provided with a detailed patient history and giving her perspective. Lastly, I am very grateful for Dr Sans-Boza for lending his time and expertise on this subject matter.
Footnotes
-
Contributors TWC: involved in the care of the patient in hospital and has written the report.
-
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
-
Competing interests None declared.
-
Provenance and peer review Not commissioned; externally peer reviewed.
- © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.
References
Use of this content is subject to our disclaimer